Cargando…

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells

Type 1 regulatory (Tr1) T cells induced by enforced expression of interleukin-10 (LV-10) are being developed as a novel treatment for chemotherapy-resistant myeloid leukemias. In vivo, LV-10 cells do not cause graft-versus-host disease while mediating graft-versus-leukemia effect against adult acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cieniewicz, Brandon, Uyeda, Molly Javier, Chen, Ping (Pauline), Sayitoglu, Ece Canan, Liu, Jeffrey Mao-Hwa, Andolfi, Grazia, Greenthal, Katharine, Bertaina, Alice, Gregori, Silvia, Bacchetta, Rosa, Lacayo, Norman James, Cepika, Alma-Martina, Roncarolo, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485690/ https://www.ncbi.nlm.nih.gov/pubmed/33054128 http://dx.doi.org/10.3324/haematol.2020.263129

Ejemplares similares

BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation
por: Uyeda, Molly Javier, et al.
Publicado: (2021)

The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application
por: Sayitoglu, Ece Canan, et al.
Publicado: (2021)

Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo
por: Sato, Yohei, et al.
Publicado: (2020)

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
por: Magnani, Chiara F, et al.
Publicado: (2011)

Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation
por: Bertaina, Alice, et al.
Publicado: (2019)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
por: Locafaro, Grazia, et al.
Publicado: (2017)

Engineered T Regulatory Type 1 Cells for Clinical Application
por: Gregori, Silvia, et al.
Publicado: (2018)

Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)
por: Comi, Michela, et al.
Publicado: (2019)

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells
por: Rossetti, Maura, et al.
Publicado: (2010)

The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
por: Gregori, Silvia, et al.
Publicado: (2012)

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
por: Gregori, Silvia, et al.
Publicado: (2015)

APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells
por: Pellerin, Laurence, et al.
Publicado: (2018)

Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape
por: Sinha, Roshani, et al.
Publicado: (2023)

Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
por: Rossi, Fiorella, et al.
Publicado: (2020)

Correction: Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
por: Rossi, Fiorella, et al.
Publicado: (2021)

Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
por: Wiebking, Volker, et al.
Publicado: (2020)

An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells
por: Gregori, Silvia, et al.
Publicado: (2005)

Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia
por: Wilkes, Mark C., et al.
Publicado: (2022)

Co-Expression of FOXP3FL and FOXP3Δ2 Isoforms Is Required for Optimal Treg-Like Cell Phenotypes and Suppressive Function
por: Sato, Yohei, et al.
Publicado: (2021)

Enhanced Response of T Cells from Murine Gammaherpesvirus 68-Infected Mice Lacking the Suppressor of T Cell Receptor Signaling Molecules Sts-1 and Sts-2
por: Cieniewicz, Brandon, et al.
Publicado: (2014)

Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells
por: Avancini, Daniele, et al.
Publicado: (2023)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
por: Chrobok, Michael, et al.
Publicado: (2019)

Human Cd25(+)Cd4(+) T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function
por: Levings, Megan K., et al.
Publicado: (2001)

Type 1 regulatory T cell-mediated tolerance in health and disease
por: Freeborn, Robert A., et al.
Publicado: (2022)

Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
por: Comi, Michela, et al.
Publicado: (2020)

Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
por: Comi, Michela, et al.
Publicado: (2021)

BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related stem cell transplantation
por: Piras, Ignazio Stefano, et al.
Publicado: (2014)

HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy
por: Amodio, Giada, et al.
Publicado: (2013)

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products
por: Sato, Yohei, et al.
Publicado: (2023)

Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
por: Song, Chang W., et al.
Publicado: (2012)

Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes
por: Creusot, Remi J., et al.
Publicado: (2016)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation
por: Gagliani, Nicola, et al.
Publicado: (2011)

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014)

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant
por: Gagliani, Nicola, et al.
Publicado: (2010)

Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host
por: Cieniewicz, Brandon, et al.
Publicado: (2016)

Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
por: Gledhill, R. M., et al.
Publicado: (1981)

HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
por: Locafaro, Grazia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1phr4rj4emcljanfnqnk0tgkd3